Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: Results of a Phase II Randomized Trial

Arsenic trioxide (ATO) is synergistic with ascorbic acid (AA) and melphalan against myeloma both in vitro and in vivo. The aim of this randomized phase II trial was to determine the safety and efficacy of a combination of ATO, melphalan, and AA as preparative regimen in 48 patients undergoing autolo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Qazilbash, Muzaffar H., Saliba, Rima M., Nieto, Yago, Parikh, Gaurav, Pelosini, Matteo, Khan, Fatima B., Jones, Roy B., Hosing, Chitra, Mendoza, Floralyn, Weber, Donna M., Wang, Michael, Popat, Uday, Alousi, Amin, Anderlini, Paolo, Champlin, Richard E., Giralt, Sergio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4112362/
https://ncbi.nlm.nih.gov/pubmed/19041063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.09.019
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg